To compare efficacy and safety of fixed drug combination of salmeterol / fluticasone and budesonide / formoterol on the lung functions in childhood patients with moderate persistent asthma

Indian Journal of Public Health Research and Development

Volumn 7, Issue 4, 2016, Pages 203-207

  Rani, Seema ^a   Rawal, Manoj ^a   Kumar, Sanjeev ^a   Lamba, Sonika ^a  

^a Genetic Centre   (India)

Author keywords

Asthma; Index epworth sleep scale salmeterol fluticasone and budesonide formoterol; Inhaled corticosteroids; Long acting beta2 agonists pittsburgh sleep quality

Indexed keywords

BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; SALMETEROL;

ARTICLE; CHILD; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG SAFETY; EPWORTH SLEEPINESS SCALE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MODERATE PERSISTENT ASTHMA; OPEN STUDY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PITTSBURGH SLEEP QUALITY INDEX; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP QUALITY; SPIROMETRY;

EID: 84991711124     PISSN: 09760245     EISSN: 09765506     Source Type: Journal    
DOI: 10.5958/0976-5506.2016.00219.9     Document Type: Article

References (17)

1. Bleecker ER, Lawrance R, Ambrose H, Goldman M. Beta2- adrenergic receptor Gly16Arg variation: effect on response tobudesonide/formoterol (BUD/FM) or budesonide (BUD; postformoterol) in children and adolescents with asthma [Abstract]. American Thoracic Society International Conference, May 16-21. 2008.
2. Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X:Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012, 94:1-8.
3. Pearce N, Ait-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. The ISAAC Phase Three Study Group. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62:758-66.
4. National Institutes of Health and National Heart Lung and Blood Institute, National Asthma Education and Prevention Programme, Expert panel report III: Guidelines for the Diagnosis and Management of Asthma, Bethesda, MD, 2007
5. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. Global Initiative for Asthma (GINA) program: the global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469-478.
6. GINA Report. Global strategy for asthma management and prevention, http://www.ginasthma.com/ 2009
7. Roth M, Zhong J, S’ng CT, Tamm M. Effect of fluticasone andformoterol combination therapy on airway remodeling. Eur Resp J 2011;38(suppl. 55): 307s.
8. Roth M, Zhong J, S’ng CT, Tamm M. The long-acting b2-agonist formoterol re-establishes the antiproliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC). Eur Resp J 2011;38(suppl. 55):612s.
9. Lipworth BJ. Antagonism of long acting β2- adrenoceptor agonism. Br J Clin Pharmacol 2002; 54: 231-45.
10. Chung KF, Adcock IM. Combination therapy of long acting beta2 adrenoceptor agonists and corticosteroids for asthma. Treat Respir Med 2004 Sep- Oct; 3 (5): 279-89.
11. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O’Byrne PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. New Eng J Med 1997 Oct; 337: 1405-11.
12. Paul M, O’Byrne PJ, Barnes PJ, Rodriguez roisin R, Runnerstrom E, Sandstrom T, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma. The OPTIMA Randomized trial. Am J Respir Crit Care Med 2001 Oct, 164: 1392-97.
13. Bateman ED, Boushey HA, Bousquet J. Can guideline defined asthma control be achieved? The Gaining Control Optimal Asthma control study. Am J Respir Crit Care Med 2004 Oct; 170: 836-44.
14. OByrne PM, Bisgaard H, Godard PP. Budesonide/ Formoterol combination therapy as both Maintenance and Reliever Medications in Asthma. Am J Respir Crit Care Med 2005 Jan; 171: 129-36
15. Marie Boltz. Best practices in Nursing care to adults [online]. 2012 [cited 2013 Feb 22]; Available from: URL:http://www.consultgerirn.org/
16. Johns MW. A new method for measuring day time sleepiness: the Epworth Sleep Scale. Sleep 1991 Oct; 14 (6): 540-45.
17. Jarjour NN, Lacouture PG, Busse WW. Theophylline inhibits the late asthmatic response to nighttime antigen challenge in patients with mild atopic asthma. Ann Allerg Asthma Immunol 1998 Jan; 81: 231-6.